SU
Suven Life Sciences Limited
SUVEN.BO · BSE
₹354.05 -2.07% (-₹7.50)
1M +8.63%
Market Cap ₹83.7B
P/E Ratio -
Div. Yield -
ROE 111.54%
Piotroski F-Score Weak
1/9Valuation
0 /100
Expensive P/S 949.38x
P/B 14.15x
P/E N/A
Growth
11 /100
Declining Rev. growth 17.48%
Book val. growth 4.59%
EPS growth N/A
Profitability
0 /100
Weak Gross margin 477.96%
Net margin 3,998.70%
Op. margin 4,228.11%
Quality
0 /100
Poor ROIC 61.09%
ROE 111.54%
ROA 56.46%
Debt
69 /100
Low Debt/Equity 0.03x
Current ratio 17.69x
Int. coverage -566.85x
Stability
26 /100
Unstable Beta 0.23x
Rev. volatility 28.70%
EPS volatility 44.60%
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o SUVEN.BO
Online
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Venkateswarlu Jasti
Employees
138
Headquarters
Hyderabad